Categories: BioTechDeliveryDevelopmentFutureLifePlatformResearchTechnology
Aegis Life, Inc. is a biotechnology company founded in early 2020 with a mission to prevent and treat existing, emerging, and future contagions. Our parent company's nucleic acid delivery technology, Fusogenix PLV, stems from more than a decade of research and development in gene delivery. We actively leverage the Fusogenix PLV platform to accelerate the discovery, clinical development, and manufacture of vaccines and therapeutics for infectious diseases.
Investors 1
Mentions in press and media 1
| Date | Title | Description |
| - | Aegis Life | “Aegis Life – We aim to prevent and treat infectious diseases” |
Reviews 0
